On August 29, 2019 CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, reported that it will participate in two upcoming investor conferences (Press release, CryoLife, AUG 29, 2019, View Source [SID1234539130]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CryoLife’s management will be presenting at the Morgan Stanley 17th Annual Healthcare Conference in New York, New York on Wednesday, September 11, 2019 at 11:40 a.m. ET and will feature an overview of the company by Pat Mackin, Chairman, President and Chief Executive Officer. The live webcast can be accessed through CryoLife’s website, www.cryolife.com, on the Investor Relations page. An archived copy of the webcast will be available for 90 days on the same website.

CryoLife’s management will also be participating in investor meetings at the Lake Street 3rd Annual B.I.G. Conference in New York, New York on Thursday, September 12, 2019. Due to the format of this event no webcast will be available.